X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CHRS

Closed

Coherus Biosciences Inc

0.7603
+0.0290 (+3.97%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 0.7313
Day's Range: 0.72 - 0.7603
Send
When Written:
 
6.84
Coherus BioSciences Inc. is a biotechnology company that develops and commercializes biosimilar drugs. Biosimilars are highly similar versions of existing biologic drugs that have been approved by regulatory agencies such as the FDA. Coherus focuses on developing biosimilars for the treatment of autoimmune diseases, cancer, and other chronic conditions. The company's lead product is UDENYCA, a biosimilar to Neulasta, which is used to reduce the risk of infection in patients receiving chemotherapy. Coherus is headquartered in Redwood City, California and was founded in 2010.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X